Method for treating leukemias using N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide for treating leukemias and solid tumors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5183821
SERIAL NO

07728025

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide (amonafide) is an effective agent for the treatment of leukemias and solid tumors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XANTHUS PHARMACEUTICALS INC300 TECHNOLOGY SQUARE CAMBRIDGE MA 02139

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alvarez-Ossorio, Rafael P Madrid, ES 2 26
Berlanga, Jose M C Madrid, ES 3 48
Brana, Miguel F Madrid, ES 5 64
De, Gamboa Cristina R F Madrid, ES 1 10
Garcia, Jesus G Madrid, ES 1 10
Roldan, Cristobal M Madrid, ES 2 26
Sanz, Antonio M Madrid, ES 2 26

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation